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ABSTRACT: Mupirocin, a commercially available antibiotic produced by Pseudomonas fluorescens and thiomarinol, iso-
lated from the marine bacterium Pseudoalteromonas sp. SANK 73390, both consist of a polyketide-derived monic acid 
homologue esterified with either 9-hydroxynonanoic acid (mupirocin, 9HN) or 8-hydroxyoctanoic acid (thiomarinol, 
8HO). The mechanisms of formation of these deceptively simple 9HN and 8HO fatty acid moieties in mup and tml re-
spectively remain unresolved. To define starter unit generation the purified mupirocin proteins MupQ, MupS and 
MacpD and their thiomarinol equivalents (TmlQ, TmlS and TacpD) have been expressed and shown to convert malonyl-
coenzyme A (CoA) and succinyl-CoA to 3-hydroxypropionoyl (3-HP) or 4-hydroxybutyryl (4-HB) fatty acid starter units 
respectively via the MupQ/TmlQ catalysed generation of an unusual bis-CoA/acyl carrier protein (ACP) thioester, fol-
lowed by MupS/TmlS catalysed reduction. Mix and match experiments show MupQ/TmlQ to be highly selective for the 
correct CoA, MacpD/TacpD were interchangeable but an alternate trans-acting ACPs from the mupirocin pathway 
(MacpA/TacpA) or a heterologous ACP (BatA) were non-functional. MupS and TmlS selectivity was more varied and 
these reductases differed in their substrate and ACP selectivity. The solution structure of MacpD determined by NMR 
revealed a C-terminal extension with partial helical character that has been shown to be important for maintaining high 
titres of mupirocin. We generated a truncated MacpD construct, MacpD_T, which lacks this C-terminal extension but 
retains an ability to generate 3-HP with MupS and MupQ, suggesting further downstream roles in protein-protein in-
teractions for this region of the ACP.   
Mupirocin is a commercially available antibiotic marketed 
as Bactroban™. It is produced by Pseudomonas fluorescens 
used for the treatment of topical skin infections and as a 
pre-operative nasal spray. Mupirocin, which consists of a 
mixture of pseudomonic acids (PAs) A-C1-4 is active against 
Gram-positive bacteria and most significantly is used clini-
cally to treat methicillin resistant Staphylococcus aureus 
(MRSA).5  The closely related thiomarinols (A-G) isolated 
from the marine bacterium Pseudoalter-
omonas sp. SANK 73390 combine scaffolds that are homol-
ogous to the pseudomonic acids with the addition of a pyr-
rothine moiety belonging to the holomycin class of antibiot-
ics.6-8 Both structures consist of a polyketide-derived monic 
acid homolog esterified with either 9-hydroxynonanoic acid 
(9HN, mupirocin) or 8-hydroxyoctanoic acid (9-HO, thi-
omarinol). 
Mupirocin and thiomarinol are assembled by a type I trans-
AT modular polyketide and fatty acid synthases 
(PKS/FAS).9 The mupirocin synthase is encoded for by a 74 
kb gene cluster consisting of 6 large open reading frames 
(ORFs), labelled mupirocin multifunctional proteins 
(MmpA to MmpF) and 29 ORFs (mupA-X and five trans-act-
ing ACPs, macpA-E) encoding a range of tailoring enzymes.10 
MmpD and MmpA encompass the principle modular PKS 
components supplemented by smaller modules MmpC, 
MmpE, MmpF/MmpB that are thought to incorporate acyl 
transferase (AT)/ enoyl reductase (ER) activities, C10 - C11 
epoxidation and fatty acid biosynthesis respectively. The 
entire thiomarinol cluster, interestingly encoded on a single 
plasmid, shares many of these common elements but lacks 
certain functions.11 For example, the TmpE oxidoreductase 
domain appears to be inactivated whereas the equivalent 
mupirocin MmpE contains an oxidoreductase domain that 
appears to be essential for epoxidation of the C10 - C11 dou-
ble bond.12 Thiomarinol contains a C4 hydroxylation that is 
absent in mupirocin and it possesses the enzymatic machin-






Figure 1. Mupirocin is a mixture of pseudomonic acids A-C. 
The structures are composed of a PKS-derived monic acid 
portion esterified to a fatty acid-derived 9-hydroxynona-
noic acid. Thiomarinol A isolated from Pseudoalter-
omonas sp. SANK 73390, includes a pyrrothine moiety, a 
shorter 8-carbon fatty acid chain, C4 hydroxylation, no 
modification of C8 and lacks the C10-C11 epoxide (resem-
bling PA-C). The minor metabolites thiomarinol B-G are 
not shown.  
A conserved structural feature between mupirocin and thi-
omarinol A is the esterification of a polyketide-derived 
monic acid portion with a fatty acid. Feeding experiments 
with 18O, 13C and 2H labelled acetates to P. fluorescens gen-
erated incorporation patterns consistent with the head-to-
tail condensation of acetate in the polyketide portion of 
both mupirocin and 9HN (Figure 2A, B). To generate the 
odd number of carbon atoms, the 9HN fatty acid portion ap-
peared to be derived from a 3-carbon starter unit incorpo-
rating a reversed acetate moiety that subsequently under-
goes three acetate condensations to generate the C9 acid.13, 
14 Similarly, a reduced level of labelled acetate incorpora-
tion was observed for C5’-C8’ of the fatty acid chain of thi-
omarinol suggesting this portion of the chain may be de-
rived from a 4-carbon starter unit. Feeding [2,3-13C2]-suc-
cinate or [2,3-13C2]-4-hydroxybutyrate gave 13C-13C cou-
pling between C6’ and C7’  showing both were incorporated 
intact suggesting that 4-hydroxybutyrate may be derived 
through reduction of a succinate or succinyl-CoA (Figure 
2C, D).15  
 
FIGURE 2. Isotopic feeding studies in the biosynthesis of 
mupirocin and thiomarinol.  A) The acetates with 
differential isotopic enrichment fed to the mupirocin pro-
ducing strain P. fluorescens NCIMB 10586 and B) The re-
sulting labelling pattern of PA-A.13, 14 C) Isotopically en-
riched precursors used in feeding studies with the thi-
omarinol WT producing strain Pseudoalter-
omonas sp. SANK 73390 and D) The resulting labelling pat-
tern of thiomarinol A where colored dots correlate the po-
sitions of incorporation with the source of the [13C] label. 
The asterisks (*) show the intact incorporation of 4-hy-
droxybutyrate, arising from succinate, into the fatty acid 
chain.15  
The starter unit in mupirocin is therefore proposed to be a 
3-hydroxypropionate derived moiety, formed by reduction 
of malonate. This undergoes three rounds of fatty acid bio-
synthesis to give a C9 chain, whereas thiomarinol presuma-
bly primes with 4-hydroxybutyrate derived moiety that un-
dergoes two elongations to give a C8 chain. In support of this 
priming, different fatty acid chain lengths have been iso-
lated in strains lacking one or more of the enzymes involved 
in polyketide chain processing, e.g. mupirocin W, dese-
poxymupirocin W and marinolic acids which show fatty 
acid lengths of C4 to C8.12, 15 To date, the mechanism for the 
formation of both of these starter units is unproven. The 
most likely origin has been hypothesized to be a three-en-
zyme cassette consisting of an ACP (MacpD/TacpD), 
MupQ/TmlQ and MupS/TmlS. Sequence homology suggests 
MupQ/TmlQ belong to the class I adenylate forming super-
family (ANL family) of enzymes that includes acyl-CoA syn-
thetases, NRPS adenylation domains (A-domains), lucifer-
ases, fatty acid-AMP ligases (FAALs) and the topologically 
distinct pimeloyl-CoA synthetase (Supporting Information 
Figure S1).16-19 Similarly, sequence homology has suggested 
MupS/TmlS to possess 3-oxoacyl ACP reductase functions. 
Mup and Tml enzymes show significant sequence identity 
(45.4%, 46.1% and 61.8% for the ACPs, MupQ/TmlQ and 
MupS/TmlS respectively) and functional homology to a cas-
sette of enzymes (DifC, DifD, DifE) from the difficidin bio-
synthetic pathway from Bacillus amyloliquefaciens. These 
enzymes were proposed to form the acryloyl thiol ester 
starter unit from reduction of pyruvate (hypothesized to be 
DifE) and a subsequent dehydration. A role for DifD in 
transferring the acryloyl thiol ester from the putative ACP 
DifC to the N-terminal priming domain of the PKS was also 
proposed.5, 20  To date the evidence for this mechanism has 
remained circumstantial and in vivo knock-out experiments 
(MupQ, MupS, MacpD) have yielded the early, but oth-
erwise uninformative shunt products, mupiric acid and 
mupirocin H.21, 22  More generally we have observed knock-
outs that generate this phenotype seem to be associated 
with late or post monic acid assembly. 
In this study we definitively prove the mechanisms for the 
generation of the starter units from both the mupirocin and 
thiomarinol biosynthetic pathways by in vitro reconstitu-
tion of these steps using purified enzymes. The three and 
four-carbon starter units are derived from malonyl- and 
succinyl-CoA respectively and proceed via the reduction of 
an unusual bis-CoA/ACP thioester.  The presence of the ACP 
is essential and MupQ/TmlQ perform the role of gatekeep-
ers that select for the correct acyl CoA. In addition, we 
demonstrate by NMR that MacpD contains an extended C-
terminus with a propensity to form an additional -helix 





for function this is not required for its activity in starter unit 
formation, suggesting a role in downstream interactions.  
RESULTS AND DISCUSSION. 
MupQ and TmlQ are adenylation domains. The homol-
ogy of MupQ and TmlQ to the ANL family (Supporting Infor-
mation Figure S1) suggested these enzymes might select 
malonyl-CoA and succinyl-CoA respectively and activate 
them to the adenylates 1 (n =1) and 2 (n=2) respectively, 
prior to attack by holo-MacpD or TacpD, forming ACP deriv-
atives 3 and 4 (Figure 3A).17, 23 MacpD, TacpD, MupQ, MupS, 
TmlQ and TmlS were cloned, recombinantly over-expressed 
and purified to homogeneity (Supporting information 
Figure S2-S4, supporting information Tables 1 and 2). 
Recombinant MacpD/TacpD were both over-expressed in 
the apo form and subsequently converted to the holo form 
using MupN.24  
Holo-MacpD (Figure 3B) was incubated with MupQ, malo-
nyl CoA and ATP. Electrospray mass spectrometry (ESMS) 
analysis showed consumption of holo-MacpD and con-
firmed quantitative formation of a new species with a mass 
consistent with 3 (observed 16097.9 Da; expected 16097.9 
Da), a three-carbon intermediate attached via thioester 
linkages to both MacpD and CoA (Figure 3C).  
Removal of ATP from the assay gave no product, confirming 
that it was essential for the reaction and MacpD was unable 
to self-malonylate.25  The requirement for ATP was con-
sistent with the formation of malonyl adenylate 1 (n=1) alt-
hough this intermediate was not isolated. Denaturing MupQ 
prevented conversion to product confirming enzymatic ac-
tivity (Supporting information Figure S5). The native thi-
omarinol system was also reconstituted in vitro by incubat-
ing TmlQ, ATP and succinyl-CoA with holo-TacpD which 
was converted to 4 with a mass of 15454.9 Da (Expected 
15455.2 Da, Figure 3D, E). This was again consistent with 
formation of a TacpD/CoA bis-thioester but with an ex-
tended four-carbon chain.  
Figure 3. Reaction of M/TacpD with native adenylation do-
mains. The phosphopantetheine arm of the ACP is repre-
sented by a wavy line.  A) Proposed reaction sequence for 
generation of bis-thioesters 3 and 4. Abbreviation Q de-
notes either MupQ or TmlQ. B) ESMS mass/charge (m/z) 
envelopes and deconvoluted mass calculation (Obs) and 
expected mass (Exp) for holo-MacpD. C) The reaction mix-
ture of holo-MacpD + MupQ + malonyl-CoA. D) Holo-TacpD. 
E) The reaction mixture of holo-TacpD + TmlQ + succinyl-
CoA.  
 
MupS encodes a Malonyl-3-CoA-1-ACP reductase. Se-
quence homology predicted MupS to be a member of the 
NAD(P)H-dependent oxidoreductase family of enzymes. A 
deposited X-ray structure of MupS (PDB: 4yxf) without co-
factor shows a classic Rossmann fold and a putative cata-
lytic tetrad (Asn125, Ser153, Tyr166 and Lys170) that may 
be capable of two successive reductive steps from the CoA 
thioester to the alcohol (Figure 4A).  The predicted reduc-
tion by MupS/TmlS was therefore investigated using the 
ACP/CoA bis-thioester product of MupQ/TmlQ. Addition of 
MupS and an excess of NADH to the 3-carbon malonyl inter-
mediate 3 bound to MacpD resulted in the reduction to a 
species consistent with the formation of MacpD-3-HP 5 
(Figure 4B). The observed ESMS trace of the derivatised 
MacpD could not however resolve either partial reduction 
to the malonic semi-aldehyde or further reduction to the al-
cohol. The product was therefore analysed via a phospho-
pantetheine ejection assay (Ppant ejection)26 whereby col-
lisional energy triggers ejection (fragmentation) of the deri-
vatised phosphopantetheine arm from the ACP, allowing 
high accuracy mass determination of the resulting low mo-
lecular weight species. This analysis yielded a species of 
333.14 Da (Figure 4C) which definitively proved genera-
tion of the 3-hydroxy-propianoyl group via two rounds of 
reduction. Similarly, the action of TmlS and NADH on 4 was 
monitored by ESMS and Ppant ejection assay which con-
firmed generation of TacpD-4-HB 6 (Figure 4D, E). Finally, 
repeating the assay with MacpD, MupQ, MupS and only one 
equivalent of NADH, an intermediate by Ppant ejection cor-
responding to the partially reduced malonic semi-aldehyde 





Figure 4. Reduction of 3- or 4- carbon ACP/CoA intermedi-
ates by native reductase domains. A) Proposed reaction se-
quence for reduction of 3 and 4 to yield MacpD-3-HP 5 and 
TacpD-4-HB 6 respectively. S denotes either MupS or TmlS. 
B) ESMS mass/charge (m/z) envelope and deconvoluted 
mass calculation (Obs) and expected mass (Exp) for MacpD 
+ MupQ + malonyl-CoA + MupS + NADH and C) Correspond-
ing Ppant ejection for B. D) Electrospray mass/charge 
(m/z) envelope for TacpD + TmlQ + succinyl-CoA + TmlS + 
NADH and E) Ppant ejection assay for D.  
 
MupQ is selective for the priming CoA.  Having shown the 
formation of the 3- or 4- carbon intermediates bound be-
tween ACP and CoA thioesters, the selectivity of the adenyl-
ation step was investigated by swapping the ACP, the ade-
nylation domain and the CoA.  
First only the CoA substrate was swapped and succinyl CoA 
was incubated with MacpD/MupQ and malonyl CoA with 
TacpD/TmlQ (Table 1, entries 2 and 6). Analysis by ESMS 
revealed that neither experiment yielded the reversed 
equivalents of the bisthioesters containing 4- or 3- carbons 
respectively. However, non-productive trans-thioesterifica-
tion of the succinyl/malonyl group from CoA to holo-
MacpD/TacpD was observed in both cases (data not 
shown).  
Next, MacpD and TacpD were swapped. Incubation of 
MacpD with succinyl CoA and TmlQ resulted in the quanti-
tative formation of a four-carbon activated intermediate 
with a mass of 16110 Da (Table 1 entry 4, Supporting in-
formation Figure S6). Similarly, when TacpD was incu-
bated with malonyl CoA and MupQ, complete conversion to 
the respective 3-carbon intermediate was observed (Table 
1 entry 8, Supporting information Figure S6). This 
demonstrated that both ACPs were compatible with non-
native adenylation domains and the adenylation domains 
alone controlled substrate selectivity. Likewise, combina-
tions of the correct ACP and substrate could not override 
the selectivity of a non-native adenylation domain and 
these combinations were inactive (Table 1 entries 3 and 
7). 
 
Entry ACP Co-factor Q Adenylation 
1 MacpD Mal MupQ Y 
2 
 
Succ MupQ N 
3   Mal TmlQ N 
4  Succ TmlQ Y 
5 TacpD Succ TmlQ Y 
6 
 
Mal TmlQ N 
7   Succ MupQ N 
8 
 
Mal MupQ Y 
9 MacpA Mal MupQ N 
10 
 
Succ TmlQ N 
11 TacpA Succ TmlQ N 
12 
 
Mal MupQ N 
13 BatA Mal MupQ N 
 
Table 1. Native and Mix and match experiments varying 
the ACP, substrate and adenylation domain (Q) and moni-
toring product formation by ESMS (Supporting Infor-
mation Figure S6 and Figure S7).  Successful reactions oc-
curred for the correct co-factor/adenylation domain pair 
(MupQ + malonyl-CoA or TmlQ + succinyl-CoA) to intro-
duce a 3- or 4-carbon unit respectively. M/TacpA and BatA 
were unable to complement for M/TacpD. 
 
MacpD and TacpD are both essential for starter unit for-
mation. In addition to MacpD and TacpD, both the mupiro-
cin and thiomarinol synthases contain further free-standing 
ACPs (in addition to the Type I and tandem array ACPs), 
several of which have not been functionally characterised. 
These include MacpA and TacpA and previous work has 
shown that MacpA is unable to complement MacpD in vivo,27 
suggesting specific interactions for each ACP. To test in vitro 
whether lack of complementation was specifically due to 
loss of starter unit formation, MacpA was incubated with 
malonyl CoA/MupQ or succinyl CoA/TmlQ under standard 
conditions (Table 1, entries 9 and 10). In either case, no 
evidence of the desired bis-thioester intermediate was de-
tected by MS. Similarly, TacpA was unable to substitute for 
TacpD (Table 1, entries 11 and 12). The only products ob-
served arose from trans-thioesterification of the CoA-
bound acyl groups to the thiol of holo-MacpA or TacpA 
(Supporting information Figure S7). When malonyl-CoA 
was used, decarboxylation was observed leading to the gen-
eration of acetyl-MacpA/TacpA (Supporting information 
Figure S7). Further evidence for the high ACP-adenylation 
domain specificity was confirmed by the inability of BatA, a 
4-helix, free-standing ACP from the -branching cassette of 
the kalimantacin biosynthetic pathway,28 to function with 
malonyl CoA/MupQ (Table 1 entry 13).  






The selectivity of the reductase domains was investigated 
through further mix and matching of substrate and MacpD. 
MupS was able to reduce the correct 3-carbon substrate 
when paired with either MacpD or TacpD (Supporting In-
formation Figure S8) but failed to act upon the 4-carbon 
substrate when combined with either ACP (Table 2 entries 
1 and 7). Conversely, TmlS was only functional when paired 
with TacpD, irrespective of which substrate was present, 
but when paired with TacpD is was able to reduce both 3- 




length S Reduction 
1 MacpD C3 MupS Y 
2   TmlS N 
3  C4 TmlS N 
4   MupS N 
5 TacpD C4 TmlS Y 
6   MupS N 
7  C3 MupS Y 
8   TmlS Y 
Table 2. Reduction of 3- or 4- carbon bis-thioesters by na-
tive or non-native reductase domains (Supporting Infor-
mation Figure S8).   
The C-terminal MacpD extension is not essential for 
starter unit generation. MacpD is an unusually large ACP 
(106 AAs) with a predicted C-terminal extension. Previous 
complementation assays showed a truncated MacpD lack-
ing the C-terminal twenty-one amino acids could partially 
rescue a acpD mutant but yielded a reduced titre of 
mupirocin, suggesting it may play a role in enhancing pro-
tein-protein interactions.27 Similarly MacpA possesses a C-
terminal extension although in this case the sequence was 
essential for mupirocin production.27 Both of the equivalent 
thiomarinol ACPs also share these C-terminal extensions. 
To further characterize MacpD we determined the three-di-
mensional structure of this protein using solution state 
NMR (Figure 5, Supporting information Table 3 for 
structural statistics, Supporting information Figure S9). 
The structure revealed the core of the protein is comprised 
of an archetypal ACP four-helix bundle, with the addition of 
partial helicity in the extended C-terminal domain (Sup-
porting information Figure S9). Although this showed 
some propensity for folding, we did not identify any inter-
actions to suggest this region associated with the core of the 
protein. The ACP presents a negatively charged/polar face 
along helices 2 and 3 and the C-terminus is a mixture of neg-
atively charged and hydrophobic groups (Figure 5). 
The presence of a partial C-terminal helix led us to investi-
gate whether this region specifically influenced starter unit 
generation. We expressed and purified a truncated MacpD 
construct (MacpD_T), lacking fifteen C-terminal residues 
(Supporting information Figure S10). When the assays 
for starter unit generation were repeated using MacpD_T, 
we were able to demonstrate formation of 3-HP-MacpD 
(Supporting information Figure S10). Preparation of 15N-
labelled full length apo MacpD and titration with MupQ 
monitored by heteronuclear single quantum coherence 
spectra (HSQC)showed the most significant chemical shift 
perturbations (CSPs) located in helix 1, and line-broadening 
of Asp47 detected in helix 2 (Figure 5C, D and G). There 
were no discernible CSPs in the C-terminal region. 
  
Figure 5. Three-dimensional solution structure of MacpD 
and 1H-15N HSQC experiments to probe protein-protein in-
teractions between MacpD and MupQ/MupS.  A) Repre-
sentative model of MacpD with helices shown as cylinders 
and the short/partial helix labelled 3. B) Surface charge 
map showing predominantly negative and polar groups 
along helices 2 and 3 and the interconnecting loop 
(Asp62). Ser45 is the site of phosphopantetheinylation. C) 
Assigned control spectrum of free apo-MacpD at 298K and 
pH 8.0 (blue) and D) In the presence of three equivalents 





perturbations are observable. E) Apo-MacpD control at 
288K, pH 8.0 and F) In the presence of two equivalents of 
MupS (red). The non-perturbed C-terminal resonances re-
main visible G) Chemical shift perturbations for apo-
MacpD titrated with MupQ. Red dots indicate broadened 
residues and those with a CSP of 0 were either proline res-
idues or not visible at pH 8.0.  
Titration with MupS however gave striking changes, with 
almost all of the resonances of MacpD being broadened or 
vanishing, but with the clear exception of resonances origi-
nating from the C-terminal helix which remained visible 
(Figure 5E and F). Together, the functional assays and NMR 
titrations confirmed that the C-terminal helix is not in-
volved in interactions with either MupQ or MupS.  
MupQ selectivity and homology. Starter unit diversity can 
imbue specific biological properties on a natural product 
and provide the opportunity for pathway engineering as a 
route to novel metabolites.  In a highly specific manner, mal-
onyl CoA is selected and activated by MupQ, whilst succinyl 
CoA is selected by TmlQ (Scheme 1A). This selectivity or 
gatekeeper role correlates with the comparative role of 
NRPS adenylation domains that are responsible for activat-
ing the correct amino acid extender units and assembling 
the correct primary sequence.29, 30 MupQ/TmlQ and NRPS A-
domains belong to the ANL family that has been divided into 
nine groups31 (of which acyl CoA synthetases and NRPSs are 
just two examples) that share a common two-step mecha-
nism of carboxylate substrate adenylation and thioesterifi-
cation.  MupQ/TmlQ are rather unusual in that the sub-
strate, malonyl- or succinyl-CoA, is already thioesterified 
but the free carboxylate undergoes adenylation and thi-
oesterification with ACP to form a bis-thioester. As far as we 
are aware there is only one similar example of bis-thioester 
formation recently reported for the ambruticin biosynthetic 
pathway. Here the ACP of an unusual FAAL-ACP didomain 
enzyme, AmbG, is proposed to activate a modular (AmbF) 
ACP-bound polyketide via formation of bis-thioester, effec-
tively cross-linking two PKS synthase components.32     
 
SCHEME 1. Starter unit generation by adenylation, thi-
oesterification and subsequent reduction. A) MacpD, 
MupQ and MupS produce a 3-hydroxypropionate whilst 
TacpD, TmlQ and TmlS produce 4-hydroxybutyrate. Ab-
breviations Q and S denotes MupQ/TmlQ and MupS/TmlS 
respectively. B) A homologous cassette of enzymes in the 
biosynthesis of difficidin produces a 3-carbon acrylate 
starter unit. C) Reduction of the ACP/CoA bis-thioester 
highlighting the selectivity required.  
Homology modelling suggests MupQ/TmlQ share the com-
mon ANL family fold characterized by two domains, an N-
terminal domain (~350 aa) and a smaller C-terminal do-
main (~100 aa), that undergo significant rearrangements 
through the catalytic cycle.23 Conserved sequence motifs 
have been identified for the ANL superfamily in both the 
NRPS adenylation domains (A1-10)29 and for aromatic ade-
nylate forming ligases (Motif I-III).33 MupQ contains, for ex-
ample, the canonical sequence motifs I/A3, II/A5, 
III/A7/A8, A10 which are responsible for acting as the 
phosphate binding loop (I), the ATP binding site and Mg2+ 
coordination (II), coordination of the ribose ring of ATP 
(III), structural roles (A6) and acyl-CoA binding (A10). 
These encompass the 100% conserved residues Glu277 
(Mg2+ binding), Gly319 (structural), Asp337/Arg351 (ATP 
binding) and Lys455 that are distributed at the 
ATP/Mg2+/Acyl-CoA/4’-PP binding site in a three-dimen-
sional model of MupQ generated by I-TASSER (Supporting 
Information Figure S11A,C).34 The corresponding motifs 
are also present in TmlQ (Supporting Information Figure 
S11). Adjacent to these motifs acyl binding pockets from a 
range of substrates of differing sizes and chemistries have 
been characterized and correlated with the polarity and 
size of the acyl binding pocket. This pocket shows a number 
of conserved residues in MupQ and TmlQ as well as subtle 
differences which may combine to select either malonate or 
succinate as substrates (Supporting Information Figure 
S11B) but will await future structural and functional stud-
ies.35 This pocket opens to a putative binding interface that 
is predominantly positively charged (residues Arg201, 
Arg232 and Lys379 in MupQ) that might provide a suitable 
binding site for the negatively charged residues likely to be 
presented by the helix 2 and 3 residues surrounding the 
phosphopantetheine arm of the ACP (e.g. Asp47, Glu56, 
Asp62, Asp66 in MacpD).  
MupS selectivity and homology. The resulting three-car-
bon bis-thioester with CoA and MacpD is subsequently re-
duced by MupS and two equivalents of NADH to form 
MacpD-3-HP. In thiomarinol biosynthesis, holo-TacpD re-
ceives activated succinyl-CoA from TmlQ, and the resulting 
four-carbon intermediate is reduced by TmlS and NADH to 
form TacpD-4-HB. Whereas the adenylation domains 
(MupQ/TmlQ) were highly substrate selective, functional 
mismatches with MupS and TmlS were less predictable and 
a degree of promiscuity was observed. Biosynthetically this 
is logical as the adenylation domains have already com-
pleted their role as a gatekeeper for selection of a three- or 
four-carbon substrate.  
MupS also shows homology to the SDR domain of the malo-
nyl-CoA reductase (MCR), a bifunctional enzyme (alcohol 
and aldehyde dehydrogenase activities) from Chloroflexus 
auranticus. The MCR generates 3-hydroxypropanoic acid 
(3HP) used in CO2 fixation from reduction of malonyl-CoA 
via the malonate semi-aldehyde.36 In the related difficidin 
biosynthetic pathway, it is therefore likely that DifE oper-
ates in a similar fashion and generates 7 which is subse-
quently dehydrated to generate the acroyl-ACP starter unit 
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MupQ/TmlQ act as gatekeeper for the correct acyl-CoA chain length






MupS and homologues evidently achieve both reductions 
using a single active site, binding a so-called ‘bulky-bulky’ 
thioester (Scheme 1C) where ‘bulky’ groups sit either side 
of the target group to be reduced as well as the bulky malo-
nic-semialdehyde following one round of reduction. The 
pantetheine arm of an ACP is derived from CoA, so the bis-
thioesters bound by MupS/TmlS show remarkable sym-
metry extending away from the centre of symmetry over 16 
or 17 consecutively bonded atoms respectively and termi-
nating in the phosphodiester bond to the conserved serine 
of helix 2 in the ACP or the adenine group of CoA. Presuma-
bly correct orientation of this intermediate is critically de-
pendent on ACP/MupS recognition to ensure substrate de-
livery from the correct portal and prevent aberrant reduc-
tion of the ACP thioester group.  Dual specificity has been 
observed previously using the Ras ADH from Ralstonia, 
which could reduce both bulky-bulky ketones as well as the 
corresponding thioester substrates (non ACP-bound). It 
was noted, however, that reduction of the bulkier thioester 
was on the order of ~500 times slower than the ketone.37   
Efforts to use in vitro assays to delineate the non-linear ar-
rangement of the enzymes of the mupirocin pathway have 
been hampered by an apparent over-abundance of type II 
ACPs including MacpA-E. MacpE has recently been con-
firmed to be involved only in the late stage processing of PA-
B to PA-A,38 MacpC is involved in -branching of the polyke-
tide backbone24 and the current study has confirmed MacpD 
is involved in starter unit production. The role of the C-ter-
minally extended MacpA is currently not defined.  
Following starter unit generation, the next step of mupiro-
cin biosynthesis is unknown.  Once loaded with 3HP MacpD 
must interact with further partner proteins involved in ei-
ther fatty acid extension of the starter unit, esterification 
with monic acid or even tetrahydrofuran formation, de-
pending on the timing of these step.12 Analysis of metabolite 
production by WT and mutant P. fluorescens strains have re-
vealed pseudomonic acids with reduced fatty acid chain 
lengths and lacking the tetrahydrofuran ring, suggesting 
these are late stage modifications and esterification may 
precede these steps. The C-terminal helix has been shown 
to be important for MacpD function, and critical for MacpA, 
and further functional and biophysical binding assays 
should be able to delineate the wider role of these extended 
ACPs and the remaining trans-acting ACP, MacpB.  Further 
candidate proteins for interaction partners include the ke-
tosynthase domains of MmpF/MmpB which may co-oper-
ate to catalyse the carbon-chain extension of these starter 
units via the Claisen condensation of ACP-bound malonyl 
extender units that may require specific docking with 
MacpD and/or MacpA/B. Some, but perhaps not all, of the 
mechanistic steps involving an ACP may be directly trans-
ferable to the thiomarinol biosynthetic pathway.  
MATERIALS AND METHODS 
Reagents were purchased from Sigma Aldrich, Thermo 
Fisher or Merck Millipore. E. coli competent cells were pur-
chased from New England Biolabs (T7 Express and 5-α) or 
Merck Millipore (Novagen BL21 (DE3)). All enzymes used 
were purchased from Thermo Fisher Scientific.  
Plasmid Preparation. Details of sequences and primers 
used are given in the Supporting Information.  The genes 
encoding M/TacpA, TacpD, MupQ, MupS, TmlQ, TmlS were 
amplified from genomic DNA and cloned into pOPINF39 
whilst the gene for MacpD and MacpD_T was synthesized 
(Thermo Fisher, GeneArt) and cloned into pET151. A C80A 
mutation was introduced into full-length MacpD for long 
term ACP stability and structural studies.  
Expression and Purification of MupQ, TmlQ, MacpD, 
TacpD, MacpD_T, MacpA and TacpA.  E. coli competent 
cells transformed with plasmid DNA were grown 37 °C for 
16 h with shaking at 200 rpm. 2 mL of this seed broth was 
used to inoculate flasks containing 200 mL LB/carb me-
dium and incubated at 37 °C with shaking at 200 rpm until 
an OD600 of 1.0 was reached. The culture was induced with 
250 µM isopropyl--D-thiogalactopyranoside (IPTG) and 
incubated for 16 h at 16 °C. Cells were harvested by centrif-
ugation (5000 x g) and re-suspended in column buffer A (50 
mM Tris-HCl, 500 mM NaCl, 10% glycerol, pH 8.0). The cells 
were lysed by sonication and the soluble fraction applied to 
a HisTrap HP 5 mL Ni column (GE Life Sciences). Protein 
was eluted using a linear gradient from 5 to 100% column 
buffer B (50 mM Tris-HCl, 100 mM NaCl, 10% glycerol, 0.8 
M imidazole, pH 8.0). 1 mL Fractions were exchanged into 
reaction buffer (50 mM Tris-HCl, 100 mM NaCl, pH 8.0) us-
ing a HiPrep 26/10 desalting column (GE Life Sciences) or 
further purified by size exclusion chromatography (Super-
dex S75) using reaction buffer. Protein was concentrated 
(maximum ~50 µM before precipitation for MupQ/TmlQ) 
and stored at 4 °C, or supplemented with 10% glycerol, ali-
quoted, flash frozen and stored at –80 °C.   
Expression and Purification of MupS and TmlS. Both en-
zymes were prepared as described above with the excep-
tion that during purification 0.5 M NaCl and 10% glycerol 
was required in the reaction buffer to prevent precipitation. 
Starter unit assay. Apo-ACP (~200 µM) was converted to 
holo-ACP by the addition of MgCl2 (10 µM), CoA (1 mM), 
MupN (1.5 µM) and TCEP (1 µM). The reaction was moni-
tored by MS and upon completion was desalted into reac-
tion buffer supplemented with 1 mM TCEP using a HiPrep 
26/10 desalting column. Holo-ACP was adjusted to ~100 
µM, aliquoted and stored at – 20 °C. To holo-ACP (100 µM) 
were added MupQ/TmlQ (5 µM), malonyl/succinyl CoA (1 
mM) and ATP (1 mM). The reaction was incubated at room 
temperature for 1 h then monitored by MS. MupS/TmlS (5 
µM) and NADH (1 mM) were added and the reaction incu-
bated for a further 1 h prior to MS analysis. For the detec-
tion of the partially reduced malonic semialdehyde, NADH 
was restricted to 0.1 mM. BatA, used as a control in these 
assays, was expressed and purified as described previ-
ously40 
ESI-MS. Samples were desalted for ESI-MS analysis using a 
C4 ZipTip™ (Millipore) per manufacturers instructions. De-
natured samples were analysed on a Synapt G2-Si (Waters) 
fitted with a TriVersa NanoMate® (Advion) using the fol-
lowing parameters: sample cone 10 V, capillary voltage 1.5 
kV, transfer collision energy 5 V. The source was set to pos-
itive mode and spectra were acquired over 600-3000 m/z 
and analysed using MassLynx™ 4.1 software. For Ppant 
ejection assays, an appropriate charge state was isolated us-
ing the MSMS functionality. The trap collision energy was 
increased until fragmentation was observed (typically 5 V – 
30 V) and spectra were collected from 200-2000 m/z.  





Single (15N) and double labelled (15N,13C) samples of MacpD 
were prepared using M9 minimal media supplemented with 
NH4Cl (15N, 99%) and or D-glucose (13C, 98%). For NMR ex-
periments the N-terminal His6-tag was removed using TEV 
protease following IMAC purification. The protein was sub-
sequently purified to homogeneity by gel filtration into re-
action buffer and desalted into H2O before being freeze-
dried for storage. NMR samples were prepared at 1-2mM by 
reconstituting freeze-dried protein in 50mM sodium phos-
phate buffer pH 6.7 supplemented with 0.1mM NaN3 and 
10% D2O. 
NMR parameters. All protein NMR experiments were ac-
quired on a Varian VNMRS 600 MHz spectrometer or a 
Bruker AVANCE III HD 700 MHz spectrometer equipped 
with cryogenically cooled detection probes. Samples were 
maintained at 20 °C and spectra referenced using 4,4-dime-
thyl-4-silapentane-1-sulfonic acid. 1H-15N HSQC experi-
ments were recorded in 90 % H2O/ 10% D2O. Details of the 
structure determination can be found in Supporting Infor-
mation. The chemical shifts and coordinates and have been 
deposited in the BMRB and PDB under accession codes 
34451 and 6TG5, respectively. For titrations with MupQ, 
MacpD spectra were recorded at 298K and pH 8.0 whereas 
titrations with MupS were recorded at 288K and pH 8.0. 
CSPs were calculated according from the 1H and 15N chemi-
cal shift change using the minimal shift approach.41 
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